Fulcrum Therapeutics, Inc. (FULC)
3.79
-0.02
(-0.52%)
USD |
NASDAQ |
Sep 24, 10:39
Fulcrum Therapeutics Cash from Operations (TTM) : -65.78M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -65.78M |
| March 31, 2026 | -63.56M |
| December 31, 2025 | -60.06M |
| September 30, 2025 | -60.03M |
| June 30, 2025 | -64.91M |
| March 31, 2025 | 7.809M |
| December 31, 2024 | -2.218M |
| September 30, 2024 | -8.615M |
| June 30, 2024 | -12.45M |
| March 31, 2024 | -92.13M |
| December 31, 2023 | -90.96M |
| September 30, 2023 | -87.50M |
| June 30, 2023 | -92.48M |
| March 31, 2023 | -99.06M |
| December 31, 2022 | -97.05M |
| September 30, 2022 | -99.21M |
| Date | Value |
|---|---|
| June 30, 2022 | -93.90M |
| March 31, 2022 | -84.36M |
| December 31, 2021 | -78.48M |
| September 30, 2021 | -76.45M |
| June 30, 2021 | -58.38M |
| March 31, 2021 | -54.68M |
| December 31, 2020 | -53.66M |
| September 30, 2020 | -38.32M |
| June 30, 2020 | -46.84M |
| March 31, 2020 | -44.79M |
| December 31, 2019 | -39.48M |
| September 30, 2019 | -41.39M |
| June 30, 2019 | -32.49M |
| March 31, 2019 | -25.83M |
| December 31, 2018 | -22.56M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Cocrystal Pharma, Inc. | -8.263M |
| CNBX Pharmaceuticals, Inc. | -0.1542M |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | -207.00M |
| Definium Therapeutics, Inc. | -166.74M |